| Product Code: ETC11891503 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Epilepsy Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Epilepsy Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Epilepsy Drug Market - Industry Life Cycle |
3.4 Israel Epilepsy Drug Market - Porter's Five Forces |
3.5 Israel Epilepsy Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Epilepsy Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Israel Epilepsy Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Epilepsy Drug Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Israel Epilepsy Drug Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
4 Israel Epilepsy Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of epilepsy in Israel |
4.2.2 Advancements in epilepsy treatment techniques and technologies |
4.2.3 Rising awareness about epilepsy and its management among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new epilepsy drugs |
4.3.2 High cost associated with epilepsy drug development and treatment |
4.3.3 Limited accessibility to epilepsy drugs in certain regions of Israel |
5 Israel Epilepsy Drug Market Trends |
6 Israel Epilepsy Drug Market, By Types |
6.1 Israel Epilepsy Drug Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Epilepsy Drug Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel Epilepsy Drug Market Revenues & Volume, By Anti-seizure Drugs, 2021 - 2031F |
6.1.4 Israel Epilepsy Drug Market Revenues & Volume, By Anticonvulsants, 2021 - 2031F |
6.1.5 Israel Epilepsy Drug Market Revenues & Volume, By Antiepileptic Drugs, 2021 - 2031F |
6.1.6 Israel Epilepsy Drug Market Revenues & Volume, By AED (Anti-Epileptic Drugs), 2021 - 2031F |
6.2 Israel Epilepsy Drug Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Epilepsy Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Israel Epilepsy Drug Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.2.4 Israel Epilepsy Drug Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.2.5 Israel Epilepsy Drug Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3 Israel Epilepsy Drug Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Epilepsy Drug Market Revenues & Volume, By Seizure Control, 2021 - 2031F |
6.3.3 Israel Epilepsy Drug Market Revenues & Volume, By Epileptic Seizures, 2021 - 2031F |
6.3.4 Israel Epilepsy Drug Market Revenues & Volume, By Drug-resistant Epilepsy, 2021 - 2031F |
6.3.5 Israel Epilepsy Drug Market Revenues & Volume, By Partial Seizures, 2021 - 2031F |
6.4 Israel Epilepsy Drug Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Epilepsy Drug Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.4.3 Israel Epilepsy Drug Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.4.4 Israel Epilepsy Drug Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4.5 Israel Epilepsy Drug Market Revenues & Volume, By Enzyme Modulators, 2021 - 2031F |
6.5 Israel Epilepsy Drug Market, By Mechanism |
6.5.1 Overview and Analysis |
6.5.2 Israel Epilepsy Drug Market Revenues & Volume, By Ion Channel Modulators, 2021 - 2031F |
6.5.3 Israel Epilepsy Drug Market Revenues & Volume, By GABA Agonists, 2021 - 2031F |
6.5.4 Israel Epilepsy Drug Market Revenues & Volume, By Glutamate Receptors, 2021 - 2031F |
6.5.5 Israel Epilepsy Drug Market Revenues & Volume, By Transdermal Patches, 2021 - 2031F |
7 Israel Epilepsy Drug Market Import-Export Trade Statistics |
7.1 Israel Epilepsy Drug Market Export to Major Countries |
7.2 Israel Epilepsy Drug Market Imports from Major Countries |
8 Israel Epilepsy Drug Market Key Performance Indicators |
8.1 Number of clinical trials for epilepsy drugs in Israel |
8.2 Adoption rate of new epilepsy drugs in the market |
8.3 Investment in research and development for epilepsy treatments |
8.4 Patient adherence to prescribed epilepsy drug regimens |
8.5 Number of healthcare facilities offering specialized epilepsy care and treatment in Israel |
9 Israel Epilepsy Drug Market - Opportunity Assessment |
9.1 Israel Epilepsy Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Epilepsy Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Israel Epilepsy Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Epilepsy Drug Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.5 Israel Epilepsy Drug Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
10 Israel Epilepsy Drug Market - Competitive Landscape |
10.1 Israel Epilepsy Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Epilepsy Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here